GJA1 and glaucoma: Aims to ameliorate the progression of many devastating chronic inflammatory diseases of the eye and other parts of the body by modulating connexin hemichannels.[56] These investigations underscore the significance of Cx43 as a vital therapeutic target across a spectrum of diseases and provide essential references for its potential application in glaucoma therapy.